Astrazeneca plc ADR [NASDAQ: AZN] closed the trading session at $72.72. The stocks have a year to date performance of 10.99 percent and weekly performance of -4.72 percent. The stock has been moved at -5.73 percent over the last six months. The stock has performed
Biotech firm AstraZeneca plc (AZN) recently announced the acquisition of biotech company Alexion Pharmaceuticals (ALXN) on Saturday 12 December. The announced transaction was large as it was worth $39 billion and that also entails a substantial premium for shareholders of Alexion. AstraZeneca has just signed
In the oil sector, in the expectation of an economic rebound in 2021 thanks to anti-Covid-19 vaccinations, optimism has continued to increase costs. In the January Nymex contract, U.S. light crude oil (WTI) rose 0.9 percent to $46.99 a barrel. In February, the Brent contract
On the back of growing market operation and the results of testing another vaccine, our indexes rose Key-U.S. indices closed in the green zone on Monday, November 23. The market was supported by statements by the British pharmaceutical company AstraZeneca on the potential 90 percent
Copyright © 2024, Powered by Smart TechOne